552 results on '"Jouneau, Stéphane"'
Search Results
2. Weight loss and outcomes in subjects with progressive pulmonary fibrosis: data from the INBUILD trial
3. Antifibrotic effects of vitamin D3 on human lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
4. Anti-fibrotic effects of nintedanib on lung fibroblasts derived from patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
5. Risk of Malnutrition in Patients With Systemic Sclerosis‐Associated Interstitial Lung Disease Treated With Nintedanib in the Randomized, Placebo‐Controlled SENSCIS Trial
6. SPLF/SMFU/SRLF/SFAR/SFCTCV Guidelines for the management of patients with primary spontaneous pneumothorax: Endorsed by the French Speaking Society of Respiratory Diseases (SPLF), the French Society of Emergency Medicine (SFMU), the French Intensive Care Society (SRLF), the French Society of Anesthesia & Intensive Care Medicine (SFAR) and the French Society of Thoracic and Cardiovascular Surgery (SFCTCV)
7. French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis – 2021 update. Full-length version
8. Effects of Ruxolitinib on fibrosis in preclinical models of systemic sclerosis
9. Malnutrition and decreased food intake at diagnosis are associated with hospitalization and mortality of idiopathic pulmonary fibrosis patients
10. Sacroiliac joint in sarcoidosis on computed tomography: a monocentric retrospective study (SISTER)
11. Treatment of Idiopathic Pulmonary Fibrosis with Capsule or Tablet Formulations of Pirfenidone in the Real-Life French RaDiCo-ILD Cohort
12. Tracheobronchopathia osteochondroplastica: clinical, bronchoscopic, and comorbid features in a case series
13. Chronic use of inhaled corticosteroids in patients admitted for respiratory virus infections: a 6-year prospective multicenter study
14. Usefulness of Body Composition CT Analysis in Patients with Idiopathic Pulmonary Fibrosis: A Pilot Study
15. Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial
16. Prognostic value and predictors of the alteration of the diffusing capacity of the lungs for carbon monoxide in systemic lupus erythematosus.
17. Prognostic Value of Autoimmune Features in a Longitudinal Study of Patients with Usual Interstitial Pneumonia
18. Low income and outcome in idiopathic pulmonary fibrosis: An association to uncover
19. Disease Behaviour During the Peri-Diagnostic Period in Patients with Suspected Interstitial Lung Disease: The STARLINER Study
20. Prospective Multicenter Validation of the Detection of ALK Rearrangements of Circulating Tumor Cells for Noninvasive Longitudinal Management of Patients With Advanced NSCLC
21. Spondyloarthrite et sarcoïdose : faux amis ou véritable association ? Revue systématique de la littérature
22. Outpatient management of primary spontaneous pneumothorax
23. Spondyloarthritis and sarcoidosis: Related or fake friends? A systematic literature review
24. Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study
25. Exclusive ambulatory management of spontaneous pneumothorax with pigtail catheters, a prospective multicentric study
26. Prognostic value and predictors of the alteration of the diffusing capacity of the lungs for carbon monoxide in systemic lupus erythematosus
27. Pleural penetration of amoxicillin and metronidazole during pleural infections: an ambispective cohort study
28. Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study)
29. Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study
30. What are the best indicators to assess malnutrition in idiopathic pulmonary fibrosis patients? A cross-sectional study in a referral center
31. Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohort
32. Predicting factors of acute exacerbation of idiopathic pulmonary fibrosis
33. Effects of vitamin D3 on human lung fibroblasts derived from patients with IPF
34. Early detection of chronic obstructive pulmonary disease in primary care: a randomised controlled trial
35. Analysis of body mass index, weight loss and progression of idiopathic pulmonary fibrosis
36. Primary spontaneous pneumothorax: French guidelines are ready for launching!
37. Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial
38. Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohort
39. Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis
40. Prevalence and risk factors of asthma in dairy farmers: Ancillary analysis of AIRBAg
41. Germline Mutations of Telomere-Related Genes are a Major Risk Factor for Liver Disease: A Multicentric Transversal Study
42. A case report of Covid-19 in an autoimmune pulmonary alveolar proteinosis: An association in tune with the times!
43. Additional file 1 of Weight loss and outcomes in subjects with progressive pulmonary fibrosis: data from the INBUILD trial
44. Risk of Malnutrition in Patients With Systemic Sclerosis‐AssociatedInterstitial Lung Disease Treated With Nintedanib in the Randomized, Placebo‐ControlledSENSCIS Trial
45. Severe hematologic complications after lung transplantation in patients with telomerase complex mutations
46. Prise en charge des exacerbations : de la ville à l’hôpital
47. Real-world safety profiles of pirfenidone and nintedanib in idiopathic pulmonary fibrosis patients
48. CD16-positive circulating monocytes and fibrotic manifestations of systemic sclerosis
49. Recommandations pratiques pour le diagnostic et la prise en charge de la fibrose pulmonaire idiopathique – Actualisation 2021. Version intégrale
50. Treating Acute Severe Eosinophilic Asthma with IL-5 Inhibitors in ICU
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.